Article
Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation.
Journal of biochemistry - 1 Jan 2000
Takahashi K, Nakayama K, Nakayama K
Abstract excerpt
p57Kip2, one of the cyclin-dependent kinase (CDK) inhibitors, has been suggested to be a tumor suppressor candidate. To elucidate its biological roles in mouse development and tumorigenesis, we created p57Kip2-deficient mice. The p57Kip2-deficient mice exhibited a cleft palate and defective bone formation resulting in severe dyspnea. Most of the p57Kip2-deficient mice died within 24 h after birth, while about 10%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
